Martin Shkreli Plans To "Modestly Lower" the Price of Daraprim by Christmas
Turing Pharmaceuticals CEO Martin Shkreli says that he plans to "modestly lower" the price of Daraprim, a life-saving drug that treats parasitic infections and helps AIDS and cancer patients, by Christmas.
In an exclusive, hour-long video interview with HIV positive journalist Josh Robbins, the former hedge fund manager discussed his role in raising the price of Daraprim from $13.50 to $750 per pill and indicated that he apparently plans to reduce the drug's cost by about ten percent. Reached later on Twitter, however, Shkreli told ATTN: that he could not confirm that Turing would lower the price of Daraprim by ten percent.
Currently, a 100-count bottle of Daraprim would cost about $75,000. Robbins asked Shkreli to define "modest" in terms of the estimated reduction amount.
"Probably ten percent off," Shkreli said in his interview with Robbins. "Where instead of $75,000 a bottle, it's $68,000 a bottle—or something like that."
Asked if he would lower the price by December 25 of this year, Shkreli said "I would commit to that—I would say 100 percent."
more
http://www.attn.com/stories/3970/martin-shkreli-daraprim-price-update
How big of him....
= new reply since forum marked as read
Kick in to the DU tip jar?
This week we're running a special pop-up mini fund drive. From Monday through Friday we're going ad-free for all registered members, and we're asking you to kick in to the DU tip jar to support the site and keep us financially healthy.
As a bonus, making a contribution will allow you to leave kudos for another DU member, and at the end of the week we'll recognize the DUers who you think make this community great.
